These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 837220)

  • 1. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamines and convulsions.
    Mason ST; Corcoran ME
    Brain Res; 1979 Jul; 170(3):497-507. PubMed ID: 466425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
    Ho BT; Meyer AL; Taylor D
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of neonatal 6-hydroxydopamine treatment on audiogenic seizures.
    Bourn WM; Chin L; Picchioni AL
    Life Sci; 1977 Sep; 21(5):701-5. PubMed ID: 904443
    [No Abstract]   [Full Text] [Related]  

  • 6. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C
    J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract]   [Full Text] [Related]  

  • 8. Ascending catecholamine systems and morphine analgesia.
    Price MT; Fibiger HC
    Brain Res; 1975 Nov; 99(1):189-93. PubMed ID: 1188982
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines.
    Doteuchi M; Costa E
    Neuropharmacology; 1973 Nov; 12(11):1059-72. PubMed ID: 4768639
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
    Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
    Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased susceptibility to seizures and decreased catecholamine turnover in spontaneously hypertensive rats.
    Goldberg ME; Milmore JE; Haubrich MK; Haubrich DR
    Eur J Pharmacol; 1975; 33(2):389-93. PubMed ID: 1183483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of locus coeruleus in decapitation convulsions of rats.
    Suenaga N; Oishi R; Fukuda T
    Brain Res; 1979 Nov; 177(1):83-93. PubMed ID: 497826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions.
    Bymaster FB; Perry KW; Fuller RW; Wong DT
    Life Sci; 1977 Jan; 20(2):275-80. PubMed ID: 839960
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of 6-hydroxydopamine quinones on catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1975 Oct; 25(4):509-16. PubMed ID: 1173817
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
    Versteeg DH; van Ree JM; Provoost AP; de Jong W
    Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamine neurotransmitters and synthetic enzymes in the spinal cord of the rat.
    Reid JL; Zivin JA; Foppen FH; Kopin IJ
    Life Sci; 1975 Mar; 16(6):975-84. PubMed ID: 1128163
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of alpha-methyl-p-tyrosine and 6-hydroxydopamine on pentylenetetrazol seizures in mice.
    Abed WT
    Pharmacol Biochem Behav; 1986 Nov; 25(5):949-52. PubMed ID: 3097680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.